Hade, I.M. et al. 2026. A Repurposed Drug Combination Overcomes Paclitaxel Resistance and Minimizes Toxicity via Dual Metabolic and pH Modulation in Breast Cancer. Asian Pacific Journal of Cancer Biology. 11, 4 (Oct. 2026), 1043–1061. DOI:https://doi.org/10.31557/APJCB.2026.11.4.1043.